Patients often worry that genetic information could be misused by insurance companies and others." - Richard Sharp, Ph.D.ĭr. "I'm especially pleased that studies of ethical issues will be part of this work. "The work has the potential to transform how we estimate disease risk in clinical practice." Kullo, professor and consultant with the Department of Cardiovascular Medicine. "We are delighted to be part of eMERGE Network phase IV in which investigators will develop and implement Polygenic Risk Scores (disease risk based on DNA variants) for common diseases, and assess outcomes following disclosure of these scores to those at the highest risk," says Principal Investigator, Dr. Iftikhar Kullo, M.D., professor and consultant with Mayo Clinic Department of Cardiovascular Medicine To enhance diversity in genetic research, more than one third of the study’s participants will belong to minority groups. The research will be done in collaboration with Mountain Park Health Center, Phoenix Arizona, a Federally Qualified Health Center. The goal of the clinical sites is to conduct and validate genomic risk-assessment and management methods for a number of common diseases in the general population, such as coronary heart disease (CHD), Alzheimer’s disease, and diabetes, by recruiting people from diverse groups, including ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. The work will be supported in part by Mayo Clinic Center of Individualized Medicine. "The work has the potential to transform how we estimate disease risk in clinical practice." - Iftikhar Kullo, M.D.ĭollars from the award will be used to build upon the Electronic Medical Records and Genomics (eMERGE) Network, a consortium of medical research organizations, to fund a coordinating center and clinical sites. part of $75 million in funding over five years to improve the role of genomics in assessing and managing disease risk. In recognition of their high impact work of advancing the field of genetic risk profiling for disease risk stratification, the National Institutes of Health (NIH) has awarded Mayo Clinic researchers Iftikhar Kullo, M.D.
0 kommentar(er)
